VivaGel® is an innovative technology being applied to a range of sexual/women’s health products by Starpharma and its partners, including:

  • VivaGel® condom
  • VivaGel® for treatment & prevention of bacterial vaginosis (BV)
  • VivaGel® for the prevention of sexually transmitted infections (STIs)

VivaGel® (SPL7013, or astodrimer sodium) is antiviral and blocks bacteria.  Several clinical studies have successfully tested the safety and efficacy of VivaGel®.

VivaGel® formulated as a mucoadhesive gel and delivered vaginally has been shown to relieve the signs and symptoms of bacterial vaginosis (BV), and to reduce risk of recurrence of BV, in clinical studies.  Further clinical studies are ongoing to confirm the effectiveness of VivaGel® in preventing recurrence of BV.





© Starpharma Holdings Limited 2017